These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8561954)

  • 1. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
    Rothman RB; Glowa JR
    Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
    Platt DM; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.
    Tella SR; Ladenheim B; Andrews AM; Goldberg SR; Cadet JL
    J Neurosci; 1996 Dec; 16(23):7416-27. PubMed ID: 8922397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction.
    Xi ZX; Gardner EL
    CNS Drug Rev; 2007; 13(2):240-59. PubMed ID: 17627675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.
    Rothman RB; Baumann MH; Prisinzano TE; Newman AH
    Biochem Pharmacol; 2008 Jan; 75(1):2-16. PubMed ID: 17897630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
    Heidbreder C
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
    Baumann MH; Char GU; De Costa BR; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1216-22. PubMed ID: 7996429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine/serotonin releasers as medications for stimulant addictions.
    Rothman RB; Blough BE; Baumann MH
    Prog Brain Res; 2008; 172():385-406. PubMed ID: 18772043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats.
    Schenk S
    Psychopharmacology (Berl); 2002 Mar; 160(3):263-70. PubMed ID: 11889495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine mechanisms of cocaine addiction.
    Kiyatkin EA
    Int J Neurosci; 1994 Sep; 78(1-2):75-101. PubMed ID: 7829294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanoxerine National Institute on Drug Abuse.
    Preti A
    Curr Opin Investig Drugs; 2000 Oct; 1(2):241-51. PubMed ID: 11249581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
    Kiyatkin EA; Brown PL
    Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
    Newman AH; Blaylock BL; Nader MA; Bergman J; Sibley DR; Skolnick P
    Biochem Pharmacol; 2012 Oct; 84(7):882-90. PubMed ID: 22781742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.
    Kiyatkin EA; Brown PL
    Brain Res; 2006 Oct; 1117(1):38-53. PubMed ID: 16956595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.